Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Changing CDK4 levels affects the number of stem cells in mouse hair follicles.

TB and BCC tumors show similar follicular differentiation patterns.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

sCD83 shows promise for treating hair loss by promoting growth and reducing inflammation.

CD10 and CD34 levels change during hair development and different hair growth stages, which could be important for hair regeneration treatments.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Targeting colon cancer stem cells might lead to better treatment results.

TLR3 activation helps improve skin and hair follicle healing in mice.

CD34+ hair follicle stem cells can become melanin-producing cells for treating skin conditions.

Lymphocytes, a type of immune cell, are crucial for wound healing as they help remodel damaged areas and reduce inflammation.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Lower proximal cup cells, not bulge stem cells, regenerate hair follicles after chemotherapy.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Wnt and Notch pathways are crucial for repairing blood stem cells after damage.

Trichoblastic fibroma and basal cell carcinoma are similar but different from trichoepithelioma.